Pierre Thadee Victor Kemula
Pierre Thadee Victor Kemula has made 1 open-market purchase worth $86k since Oct 7, 2026, in 1 company. The latest: $86k of AGMB, filed Oct 7, 2026, scored 76 out of 100.
CFO, AgomAb Therapeutics NV
Follow Pierre Thadee Victor Kemula, freeOpen the live feed
A free account gets an alert the minute a new buy or sale is filed.
Purchases
| Filed | Stock | Stake | Score | Bought | 1 week | 1 month |
|---|---|---|---|---|---|---|
| Oct 7 Form 4 (opens sec.gov) |
AGMBAgomAb Therapeutics NV · CFOCFO · 3 insiders buying · Near 52-week low | New position | 76 | $86k 10,000 at $8.59 |
−1.3% | waiting |
Track record (hypothetical): a week after the filing, these buys averaged −1.3% (0% up, 1 measured).
Questions
What stock has Pierre Thadee Victor Kemula bought?
AGMB (AgomAb Therapeutics NV), all on the open market and reported on SEC Form 4.
When did Pierre Thadee Victor Kemula last buy?
Oct 7, 2026: 10,000 shares of AGMB at $8.59, $86k in all (Form 4 (opens sec.gov)).
Has Pierre Thadee Victor Kemula filed a notice of a planned sale?
Not in the filings on record. A Form 144 is the notice an insider must file before selling restricted or control shares, and it lands on EDGAR before the sale is reported.
Is Pierre Thadee Victor Kemula a routine or an opportunistic buyer?
There isn't enough history to say yet.
Data as of Oct 7, 2026, from SEC EDGAR Form 4 filings: open-market purchases (code P) of $25,000 or more, and open-market sales. Every row links to its filing. Scores summarise what a filing says (how the score works); outcomes are hypothetical, from the first close after the filing, and past results don't predict future ones. Disclaimer